Sage Therapeutics’ Drug for Postpartum Depression Gets FDA Nod

  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The FDA approved Sage Therapeutics' Zulresso, the first medication specifically for women with postpartum depression

Postpartum depression is a type of mood disorder that affects some women after childbirth, causing sadness and loss of interest in activities. Symptoms can start during pregnancy, and the condition can interfere with mother-child emotional bonding.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Side effects?

Really? We need yet another drug to make a fortune for Pharma & who knows what side effects? Yes, I know PPD is serious & it’s likely _some_ ppl need meds. Shd be a more holistic solution: therapy, help home, 24/7 access to a known midwife, not just throw meds the problem

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sage stock rises after FDA approves first postpartum depression treatment Zulresso
Source: CNBC - 🏆 12. / 72 Read more »

Sage stock rises after FDA approves first postpartum depression treatment Zulresso
Source: CNBC - 🏆 12. / 72 Read more »

FDA approves first postpartum depression drugThe US Food and Drug Administration announced on Tuesday it has approved the first medication specifically targeted to treat postpartum depression in women. The treatment is administered as a single 60-hour IV drip, and could offer new hope to moms. Comparing my middle school to the NFL. I thought Birth Control pills were already approved by the FDA Always great to see advancements in medicine for depression. I hope it works. What’s in it?
Source: cnnbrk - 🏆 393. / 55 Read more »

‘Transformative’: FDA approves first drug for postpartum depressionBrexanolone is not a pill. The drug is delivered intravenously over the course of a 60-hour infusion, meaning it must be administered in a medically supervised setting, such as a skilled facility or a hospital, rather than at patients’ homes. It’s also a false hope, because it’s $20-30k per infusion, not covered by insurance. Ridiculous. For the low, low price of $35,000 😉 You’ll only be transformed if you can afford it: First Postpartum Depression Drug Approved by FDA Could Cost up to $35,000 for 1 Treatment
Source: NBCNews - 🏆 10. / 86 Read more »